Most newly discharged patients who recently recovered from COVID-19 produce virus-specific antibodies and T cells, suggests a study published on May 3rd in the journal Immunity, but the responses of different patients are not all the same. While the 14 patients examined in the study showed wide-ranging immune responses, results from the 6 of them that were assessed at two weeks after discharge suggest that antibodies were maintained for at least that long.
- Better diet and glucose uptake in the brain lead to longer life in fruit flies
- Rapid blood test identifies COVID-19 patients at high risk of severe disease
- New study connects religiosity in US South Asians to cardiovascular disease
- USask study finds COVID isolation worsens student diets, inactivity, and alcohol intake
- Scientists offer road map to improve environmental observations in the Indian Ocean